Mitsubishi Tanabe Pharma (4508)

  • Get an in-depth profile of Mitsubishi Tanabe Pharma, including a general overview of the company's business and key management, as well as employee data and location and contact information.
2,006.0 0.0 (0.00%)
Close JPY Disclaimer

Mitsubishi Tanabe Pharma Company Profile

Industry
Pharmaceuticals
Sector
Healthcare
Employees
6756
Equity Type
ORD
Mitsubishi Tanabe Pharma Corporation engages in the manufacture and sale of pharmaceuticals and OTC products in Japan, Europe, North America, other Asian countries, and internationally. The company primarily offers drugs for central nervous system, immuno-inflammation, and diabetes and kidney disorders; and vaccines for influenza, measles and rubella, encephalitis, diphtheria, pertussis, tetanus, and poliomyelitis. It also provides OTC products, including skin treating agents, digestive drinks and medicines, and nutrient foods. The company operates through a branch office in Tokyo; sales offices in Hokkaido, Tohoku, Kitakantokoshinetsu, Tokyo, Chiba, Saitama, Tokai, Yokohama, Kyoto, Osaka, Kobe, Chushikoku, and Kyushu; and research centers in Yokohama, Onada, and Shonan. Mitsubishi Tanabe Pharma Corporation was formerly known as Tanabe Seiyaku Co. Ltd. and changed its name to Mitsubishi Tanabe Pharma Corporation on October 2, 2007. The company was founded in 1678 and is headquartered in Osaka, Japan. Mitsubishi Tanabe Pharma Corporation operates as a subsidiary of Mitsubishi Chemical Holdings Corporation.
Contact Information
Address
Osaka,541-8505 Japan
Phone
81 6 6205 5085
Fax
81 6 6205 5262
Web
https://www.mt-pharma.co.jp

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles